Larson Financial Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.6K | Buy |
384
+200
| +109% | +$8.64K | ﹤0.01% | 1565 |
|
|
2025
Q1 | $6.36K | Buy |
184
+1
| +0.5% | +$35 | ﹤0.01% | 1801 |
|
|
2024
Q4 | $5.02K | Hold |
183
| – | – | ﹤0.01% | 1659 |
|
|
2024
Q3 | $4.66K | Hold |
183
| – | – | ﹤0.01% | 1669 |
|
|
2024
Q2 | $4.64K | Buy |
+183
| New | +$4.64K | ﹤0.01% | 1457 |
|
|
2023
Q3 | – | Sell |
-460
| Closed | -$7.91K | – | 1711 |
|
|
2023
Q2 | $7.91K | Hold |
460
| – | – | ﹤0.01% | 1000 |
|
|
2023
Q1 | $7.63K | Hold |
460
| – | – | ﹤0.01% | 993 |
|
|
2022
Q4 | $3.51K | Hold |
460
| – | – | ﹤0.01% | 1101 |
|
|
2022
Q3 | $5K | Hold |
460
| – | – | ﹤0.01% | 942 |
|
|
2022
Q2 | $4K | Hold |
460
| – | – | ﹤0.01% | 889 |
|
|
2022
Q1 | $5K | Buy |
+460
| New | +$5K | ﹤0.01% | 779 |
|
|
2021
Q4 | – | Sell |
-253
| Closed | -$12K | – | 1066 |
|
|
2021
Q3 | $12K | Buy |
+253
| New | +$12K | ﹤0.01% | 548 |
|